Rekah Pharmaceutical Prod (XTAE:REKA) Total Liabilities : ₪285.2 Mil (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Rekah Pharmaceutical Prod Total Liabilities?

Rekah Pharmaceutical Prod's Total Liabilities for the quarter that ended in Dec. 2024 was ₪285.2 Mil.

Rekah Pharmaceutical Prod's quarterly Total Liabilities increased from Jun. 2024 (₪282.68 Mil) to Sep. 2024 (₪289.98 Mil) but then declined from Sep. 2024 (₪289.98 Mil) to Dec. 2024 (₪285.24 Mil).

Rekah Pharmaceutical Prod's annual Total Liabilities increased from Dec. 2022 (₪286.34 Mil) to Dec. 2023 (₪329.14 Mil) but then declined from Dec. 2023 (₪329.14 Mil) to Dec. 2024 (₪285.24 Mil).

Rekah Pharmaceutical Prod Total Liabilities Historical Data

The historical data trend for Rekah Pharmaceutical Prod's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rekah Pharmaceutical Prod Total Liabilities Chart

Rekah Pharmaceutical Prod Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

254.10

264.03

286.34

329.14

285.24

Rekah Pharmaceutical Prod Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															329.14	326.11	282.68	289.98	285.24

Rekah Pharmaceutical Prod Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Rekah Pharmaceutical Prod's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	158.043	+	(97.321	+	19.296
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	10.584	+	0)
	=	285.2

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	447.22	-	161.976
	=	285.2

Rekah Pharmaceutical Prod's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	158.043	+	(97.321	+	19.296
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	10.584	+	0)
	=	285.2

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	447.22	-	161.976
	=	285.2

Rekah Pharmaceutical Prod Total Liabilities Related Terms

Thank you for viewing the detailed overview of Rekah Pharmaceutical Prod's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Rekah Pharmaceutical Prod Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rekah Pharmaceutical Prod Ltd (XTAE:REKA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Hamelacha Street, Holon, ISR

Website

http://www.rekah.co.il

Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.

Rekah Pharmaceutical Prod Headlines

No Headlines